Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Paid-in Capital
Accumulated Other Comprehensive Income (Loss), net of tax
Retained Earnings (Deficit)
Beginning balance (in shares) at Dec. 29, 2024   22,050        
Beginning balance at Dec. 29, 2024 $ (84,269) $ 22 $ (164,937) $ 233,667 $ (62) $ (152,959)
Beginning balance (in shares) at Dec. 29, 2024     4,647      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (335)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 241   $ 11,993 (11,752)    
Non-cash stock compensation 2,365     2,365    
Net income (loss) 1,249         1,249
Other comprehensive income (loss) 2       2  
Ending balance (in shares) at Apr. 20, 2025   22,050        
Ending balance at Apr. 20, 2025 (80,412) $ 22 $ (152,944) 224,280 (60) (151,710)
Ending balance (in shares) at Apr. 20, 2025     4,312      
Beginning balance (in shares) at Dec. 29, 2024   22,050        
Beginning balance at Dec. 29, 2024 (84,269) $ 22 $ (164,937) 233,667 (62) (152,959)
Beginning balance (in shares) at Dec. 29, 2024     4,647      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 5,242          
Other comprehensive income (loss) 2          
Ending balance (in shares) at Jul. 13, 2025   22,050        
Ending balance at Jul. 13, 2025 (78,643) $ 22 $ (147,645) 216,757 (60) (147,717)
Ending balance (in shares) at Jul. 13, 2025     4,164      
Beginning balance (in shares) at Apr. 20, 2025   22,050        
Beginning balance at Apr. 20, 2025 (80,412) $ 22 $ (152,944) 224,280 (60) (151,710)
Beginning balance (in shares) at Apr. 20, 2025     4,312      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (148)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 230   $ 5,299 (5,069)    
Non-cash stock compensation (2,454)     (2,454)   0
Net income (loss) 3,993       0 3,993
Other comprehensive income (loss) 0          
Ending balance (in shares) at Jul. 13, 2025   22,050        
Ending balance at Jul. 13, 2025 $ (78,643) $ 22 $ (147,645) 216,757 (60) (147,717)
Ending balance (in shares) at Jul. 13, 2025     4,164      
Beginning balance (in shares) at Dec. 28, 2025 18,009 22,050        
Beginning balance at Dec. 28, 2025 $ (106,348) $ 22 $ (143,247) 213,180 (60) (176,243)
Beginning balance (in shares) at Dec. 28, 2025 4,041   4,041      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (243)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan $ 26   $ 8,674 (8,648)    
Non-cash stock compensation 1,366     1,366    
Net income (loss) (2,178)         (2,178)
Equity issuance costs [1] 479     479    
Ending balance (in shares) at Apr. 19, 2026   22,050        
Ending balance at Apr. 19, 2026 $ (106,655) $ 22 $ (134,573) 206,377 (60) (178,421)
Ending balance (in shares) at Apr. 19, 2026     3,798      
Beginning balance (in shares) at Dec. 28, 2025 18,009 22,050        
Beginning balance at Dec. 28, 2025 $ (106,348) $ 22 $ (143,247) 213,180 (60) (176,243)
Beginning balance (in shares) at Dec. 28, 2025 4,041   4,041      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (1,792)          
Other comprehensive income (loss) $ (2)          
Ending balance (in shares) at Jul. 12, 2026 18,888 22,050        
Ending balance at Jul. 12, 2026 $ (105,590) $ 22 $ (111,812) 184,297 (62) (178,035)
Ending balance (in shares) at Jul. 12, 2026 3,162   3,162      
Beginning balance (in shares) at Apr. 19, 2026   22,050        
Beginning balance at Apr. 19, 2026 $ (106,655) $ 22 $ (134,573) 206,377 (60) (178,421)
Beginning balance (in shares) at Apr. 19, 2026     3,798      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (636)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 186   $ 22,761 (22,575)    
Non-cash stock compensation 495     495    
Net income (loss) 386         386
Other comprehensive income (loss) $ (2)       (2)  
Ending balance (in shares) at Jul. 12, 2026 18,888 22,050        
Ending balance at Jul. 12, 2026 $ (105,590) $ 22 $ (111,812) $ 184,297 $ (62) $ (178,035)
Ending balance (in shares) at Jul. 12, 2026 3,162   3,162      
[1] Represents the reclassification of at-the-market equity offering issuance costs from equity to other (gains) charges upon termination of the offering. See Note 6. Other (Gains) Charges, net, for further information.